Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan.
Yuji MinegishiAkihiko GemmaSakae HommaKazuma KishiArata AzumaTakashi OguraNaoki HamadaHiroyuki TaniguchiNoboru HattoriYasuhiko NishiokaKiminobu TanizawaTakeshi JohkohTakuma YokoyamaKazutaka MoriYoshio TaguchiMasahito EbinaNaohiko InaseKoichi HagiwaraHiroshi OhnishiHiroshi MukaeYoshikazu InoueKazuyoshi KuwanoHirofumi ChibaKen OhtaYoshinori TaninoFumikazu SakaiYukihiko SugiyamaPublished in: ERJ open research (2020)
Combination chemotherapies consisting of CP or CE are candidates for standard first-line treatments for patients with advanced lung cancer accompanied by IIP. Second-line chemotherapy should be considered for patients remaining fit enough to receive it.
Keyphrases
- end stage renal disease
- chronic obstructive pulmonary disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- public health
- locally advanced
- liver failure
- prognostic factors
- peritoneal dialysis
- drug induced
- squamous cell carcinoma
- cross sectional
- patient reported outcomes
- acute respiratory distress syndrome